OSR Holdings (OSRH) updates VXM01 license agreement exhibit in 8-K/A
Filing Impact
Filing Sentiment
Form Type
8-K/A
Rhea-AI Filing Summary
OSR Holdings, Inc. filed an amended current report to correct an exhibit attached to a prior disclosure. The amendment replaces Exhibit 10.1 with a corrected version of the Global License Agreement for VXM01, dated March 23, 2026, among Vaximm AG, OSR Holdings, Inc. and BCM Europe AG. The update is described as fixing clerical errors, including the stated per share price, and does not change any other information contained in the original report.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 9.01 — Financial Statements and Exhibits
1 item
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Common stock par value: $0.0001 per share
Warrant exercise price: $11.50 per share
Form type: 8-K/A
+2 more
5 metrics
Common stock par value
$0.0001 per share
Par value of OSR Holdings common stock listed on Nasdaq
Warrant exercise price
$11.50 per share
Exercise price of redeemable warrants trading on Nasdaq
Form type
8-K/A
Amended current report correcting Exhibit 10.1 only
Exhibit 10.1 date
March 23, 2026
Date of Global License Agreement for VXM01
Amendment purpose
Clerical corrections
Replaces Exhibit 10.1 to fix errors including per share price
Key Terms
Global License Agreement, Emerging growth company, Inline XBRL, Redeemable warrants
4 terms
Global License Agreement financial
"Global License Agreement for VXM01, dated March 23, 2026"
Emerging growth company regulatory
"Emerging growth company Explanatory Note"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
Redeemable warrants financial
"Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share"
A redeemable warrant is a tradable right that lets its holder buy a company’s shares at a fixed price before a set date, but the issuer has the contract power to cancel (redeem) the warrant early under agreed terms. For investors this matters because early redemption can force decision-making, change the timing of when new shares might be created, and affect potential gains or dilution—much like a store coupon that the issuer can cancel by paying you off instead of letting you use it.
FAQ
What did OSR Holdings (OSRH) change in this amended 8-K/A?
OSR Holdings updated its filing only to replace Exhibit 10.1 with a corrected Global License Agreement. The company states the changes address clerical errors, including the per share price, and do not alter any other disclosures from the original report.
Does this OSR Holdings (OSRH) amendment affect prior financial or business disclosures?
The amendment states it does not modify, amend, or update any other disclosures in the original report. Only the exhibit containing the Global License Agreement was corrected for clerical issues, including the stated per share price, leaving prior narrative unchanged.
What is Exhibit 10.1 in OSR Holdings’ (OSRH) amended filing?
Exhibit 10.1 is the Global License Agreement for VXM01 dated March 23, 2026. It is between Vaximm AG, OSR Holdings, Inc. and BCM Europe AG, and this amendment replaces that exhibit with a corrected version reflecting clerical fixes.
Does OSR Holdings (OSRH) report any new transactions in this 8-K/A?
No new transactions are introduced in the amendment. It focuses solely on replacing Exhibit 10.1 with a corrected Global License Agreement and explicitly notes that no other parts of the original report are modified or updated.